Dec 10, 09:09
Dec 10, 09:07
AnnouncementsVenus Remedies set to tap Italian market with meropenem
AnnouncementsVenus Remedies: Outcome of AGM
|Company Name||Last Price||%
|Dr Reddys Labs||2450.80||0.05||2545.00||1764.00||41,688.04|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Venus Remedies is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 270.15 crore.The company has reported a standalone sales of Rs 125.24 crore and a Net Profit of Rs 15 crore for the quarter ended Sep 2013.
The company management includes Pawan Chaudhary - Chairman & Managing Director, Manu Chaudhary - Joint Managing Director, Peeyush Jain - Deputy Managing Director, Ashutosh Jain - Executive Director, Gilbert Wenzel - Non Executive Director, S K Chadha - Non Executive Director, Jagdish Chander - Non Executive Director, Hari Pal Verma - Non Executive Director, Soumitra Sengupta - Non Executive Director.
It is listed on the BSE with a BSE Code of 526953 and the NSE with an NSE Code of VENUSREM.
Its Registered office is at S.C.O. 857, Cabin No. 10, 2nd Floor,,N.A.C. Manimajra Chandigarh,Chandigarh - 160101.
Their Registrars are Link Intime India Pvt. Ltd.